Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal for Immunotherapy of Cancer|November 30, 2023
Evaluation of tissue- and plasma-derived tumor mutational burden (TMB) and genomic alterations of interest in CheckMate 848, a study of nivolumab combined with ipilimumab and nivolumab alone in patients with advanced or metastatic solid tumors with high TMBJie He, Natallia Kalinava, Parul Doshi, et al.The Journal of Urology|July 24, 2009
Multicenter evaluation of an investigational prostate cancer methylation assayJonathan Baden, George Green, Jennifer Painter, et al.The New England Journal of Medicine|April 17, 2018
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational BurdenMatthew D Hellmann, Tudor-Eliade Ciuleanu, Adam Pluzanski, et al.Cellular and Molecular Life Sciences : CMLS|March 25, 2022
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor typesNicholas Willumsen, Christina Jensen, George Green, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2019
First-Line Nivolumab Plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as BiomarkersNeal Ready, Matthew D Hellmann, Mark M Awad, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 5, 2026
Agreement Across 10 Artificial Intelligence Models in Assessing Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Breast Cancer Whole-Slide ImagesBrittany McKelvey, Pedro A Torres-Saavedra, Jessica Li, et al.Pageof 2